AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
AMPLIFI
1 other identifier
interventional
48
1 country
1
Brief Summary
The AMPLIFI study (Adaptive Modulation of Plasticity through Lactate and Fitness Interventions) investigates how short-term aerobic exercise influences brain plasticity and learning in older adults and stroke survivors. The study compares three groups: one performing aerobic cycling at an intensity that elevates lactate levels, one performing low-intensity exercise, and one receiving health education without exercise. All participants will complete motor learning tasks and undergo brain-stimulation testing using transcranial magnetic stimulation (TMS) to assess how well the brain responds to training. The goal is to understand whether different types of exercise can improve brain function, movement, and memory, and how the body's response to exercise (like lactate levels) might support brain health. This research may help identify low-cost, non-invasive interventions-such as targeted exercise-that improve motor and cognitive outcomes in aging and stroke recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedStudy Start
First participant enrolled
May 14, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
Study Completion
Last participant's last visit for all outcomes
January 1, 2030
April 17, 2026
April 1, 2026
3.3 years
April 3, 2025
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor Learning Performance (12-Digit Serial Reaction Time Task)
Motor learning is assessed using the 12-digit Serial Reaction Time Task (SRTT), a computer-based measure of implicit motor sequence learning. Participants respond to visual cues by pressing buttons in a fixed or random sequence. Learning is quantified by changes in reaction time and accuracy across structured and unstructured trials. A learning index is derived by comparing performance between patterned (learning) and random sequences.
Baseline, Day 2, Day 3, Day 4, and Day 5
Secondary Outcomes (4)
Change in Long-Interval Intracortical Inhibition (LICI)
Baseline, Day 5
Change in Intracortical Facilitation (ICF)
Baseline, Day 5
Change in Blood Lactate Concentration
Day 2, Day 3, Day 4
Change in Executive Function (D-KEFS Verbal Fluency and Stroop Tests)
Day 1 and Day 5
Study Arms (4)
Aerobic Exercise at Lactate Threshold
EXPERIMENTALParticipants complete a 20-minute aerobic cycling session at individually prescribed intensity to achieve lactate threshold, based on VO2 max and blood lactate data. This condition is designed to induce metabolic stress and engage neuromodulatory pathways related to cortical plasticity. Participants complete TMS and motor learning tasks before and after the intervention.
Low-Intensity Aerobic Exercise
ACTIVE COMPARATORParticipants complete a 20-minute cycling session at a light workload, below lactate threshold. This condition controls for movement and engagement without significant metabolic challenge. TMS and motor learning outcomes are assessed pre- and post-intervention.
Education Control
PLACEBO COMPARATORParticipants engage in a 20-minute health education session instead of exercise. This arm serves as a non-exercise control to isolate the effects of physical exertion on neuroplasticity. All outcome measures are collected similarly to the exercise groups.
Active Comparator: Moderate-Intensity Aerobic Exercise
ACTIVE COMPARATORArm Description: Participants complete a 20-minute cycling session at a moderate workload, surrounding lactate threshold. This condition controls for movement and engagement without advanced metabolic challenge. TMS and motor learning outcomes are assessed pre- and post-intervention.
Interventions
Participants receive a 20-minute session of health education content (e.g., wellness, healthy aging). No exercise is performed. Participants undergo TMS and motor learning testing before and after the session. This condition is used to control for attention and cognitive engagement without physical activity.
Participants cycle on a stationary ergometer at an intensity prescribed to reach their lactate threshold, guided by VO2 max results and lactate sampling. The session lasts approximately 20 minutes and is preceded and followed by TMS assessments and a structured motor learning task. This condition is designed to evaluate the effect of exercise-induced metabolic stress on cortical inhibition and motor learning.
Participants perform 20 minutes of cycling at a light workload below their lactate threshold. Exercise intensity is individualized using heart rate and perceived exertion (Borg RPE scale), avoiding significant metabolic activation. TMS and motor learning are assessed pre- and post-exercise. This condition serves as an active comparator to assess the impact of exercise intensity.
Participants cycle on a stationary ergometer at an intensity prescribed to surround, but not exceed their lactate threshold, guided by VO2 max results and lactate sampling. The session lasts approximately 20 minutes and is preceded and followed by TMS assessments and a structured motor learning task. This condition is designed to evaluate the effect of moderate exercise-induced metabolic stress on cortical inhibition and motor learning.
Eligibility Criteria
You may qualify if:
- For All Participants:
- Able to provide informed consent
- Right-handed (for TMS consistency)
- English-speaking
- Clearance for moderate-intensity aerobic exercise
- Able to safely sit and pedal a stationary cycle ergometer
- No contraindications to TMS (e.g., no metal in skull, pacemakers, or seizure history)
- Younger Adults (18-35):
- No history of neurological or psychiatric conditions
- Not currently on medications that affect the central nervous system
- Older Adults (60-85):
- No diagnosis of dementia
- Independent in activities of daily living
- No stroke history
- Stroke Survivors (40-85):
- +3 more criteria
You may not qualify if:
- History of epilepsy or seizures
- Current substance abuse or uncontrolled psychiatric disorder
- Severe cardiovascular disease or unstable medical condition
- Pregnancy
- Contraindications to TMS or exercise testing (e.g., implanted neurostimulators, severe hypertension)
- Participation in another interventional trial within the past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CH19 933 19th St S
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Keith McGregor, PhD
Keith McGregor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Director of Research
Study Record Dates
First Submitted
April 3, 2025
First Posted
April 29, 2025
Study Start (Estimated)
May 14, 2026
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
January 1, 2030
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
No, not beyond the original research team.